IN2013CH05441A - - Google Patents

Download PDF

Info

Publication number
IN2013CH05441A
IN2013CH05441A IN5441CH2013A IN2013CH05441A IN 2013CH05441 A IN2013CH05441 A IN 2013CH05441A IN 5441CH2013 A IN5441CH2013 A IN 5441CH2013A IN 2013CH05441 A IN2013CH05441 A IN 2013CH05441A
Authority
IN
India
Prior art keywords
preparation
pharmaceutical compositions
same
stabilized pharmaceutical
solvates
Prior art date
Application number
Other languages
English (en)
Inventor
Chandrashekhar Kandi
Nagaprasad Vishnubhotla
Sreekanth Manikonda
Anil Kumar Reddy
Arjuna Rao Panchada
Sivakumaran Meenakshisunderam
Original Assignee
Aurobindo Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aurobindo Pharma Ltd filed Critical Aurobindo Pharma Ltd
Priority to IN5441CH2013 priority Critical patent/IN2013CH05441A/en
Priority to US14/544,126 priority patent/US20150157618A1/en
Publication of IN2013CH05441A publication Critical patent/IN2013CH05441A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IN5441CH2013 2013-11-26 2013-11-26 IN2013CH05441A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN5441CH2013 IN2013CH05441A (ja) 2013-11-26 2013-11-26
US14/544,126 US20150157618A1 (en) 2013-11-26 2014-11-26 Stabilized pharmaceutical compositions of dabigatran and process for preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN5441CH2013 IN2013CH05441A (ja) 2013-11-26 2013-11-26

Publications (1)

Publication Number Publication Date
IN2013CH05441A true IN2013CH05441A (ja) 2015-05-29

Family

ID=53270042

Family Applications (1)

Application Number Title Priority Date Filing Date
IN5441CH2013 IN2013CH05441A (ja) 2013-11-26 2013-11-26

Country Status (2)

Country Link
US (1) US20150157618A1 (ja)
IN (1) IN2013CH05441A (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017103945A1 (en) * 2015-12-15 2017-06-22 Strides Shasun Limited Pharmaceutical compositions
TR201617984A2 (tr) * 2016-12-07 2018-06-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Dabi̇gatranin farmasöti̇k kompozi̇syonlari
JP2018104425A (ja) * 2016-12-26 2018-07-05 日本ケミファ株式会社 ダビガトランエテキシラートまたはその薬学的に許容される塩を含有する錠剤
JP2018184375A (ja) * 2017-04-27 2018-11-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ダビガトランエテキシラート又は医薬的に許容されるその塩を含む錠剤及びその製造方法
TR201722323A2 (tr) * 2017-12-27 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Dabi̇gatranin oral farmasöti̇k kompozi̇syonlari
CN110354123B (zh) * 2018-04-04 2023-11-24 上海汉都医药科技有限公司 含达比加群酯的药物组合物及其制备方法
CN110354122B (zh) * 2018-04-04 2023-07-28 上海汉都医药科技有限公司 含达比加群酯的药物组合物及其制备方法
WO2020032885A2 (en) * 2018-05-04 2020-02-13 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Capsule-in-capsule compositions of dabigatran etexilate
TR201905308A2 (tr) * 2019-04-09 2020-10-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi A capsule formulation of dabigatran etexilate
JP2021014411A (ja) * 2019-07-10 2021-02-12 日医工株式会社 安定なダビガトランエテキシラート製剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080014257A1 (en) * 2006-07-14 2008-01-17 Par Pharmaceutical, Inc. Oral dosage forms
EP2155167A2 (en) * 2007-06-04 2010-02-24 Egalet A/S Controlled release pharmaceutical compositions for prolonged effect
US8962574B2 (en) * 2008-11-11 2015-02-24 Boehringer Ingelheim International Gmbh Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved safety profile over conventional warfarin therapy
PL2542224T3 (pl) * 2010-03-01 2014-12-31 Ratiopharm Gmbh Doustna kompozycja farmaceutyczna zawierająca eteksylan dabigatranu

Also Published As

Publication number Publication date
US20150157618A1 (en) 2015-06-11

Similar Documents

Publication Publication Date Title
IN2013CH05441A (ja)
MX2018013668A (es) Inhibidores de virus de hapatitis c.
PH12019500163A1 (en) Tetrahydro- and dihydro-isoquinoline prmt5 inhibitors and uses thereof
MX2015012850A (es) Inhibidores de la arginina metiltransferasa y usos de los mismos.
WO2014153100A3 (en) Arginine methyltransferase inhibitors and uses thereof
WO2014153235A3 (en) Arginine methyltransferase inhibitors and uses thereof
TN2014000155A1 (en) Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
IN2014MN02658A (ja)
MX2017008518A (es) Compuestos de isoquinolina para el tratamiento de virus de inmunodeficiencia humana (vih).
PH12019501639A1 (en) Jaki selective inhibitors
IN2014MN02245A (ja)
PH12016501462A1 (en) Neprilysin inhibitors
MX2018004304A (es) DERIVADOS DE QUINOXALINA Y PIRIDOPRAZINA COMO INHIBIDORES DE PI3Kß.
IN2013MU03862A (ja)
WO2016142821A3 (en) Compositions containing a thrombin inhibitor
MX2016016039A (es) Formulacion farmaceutica para reducir la frecuencia de micción y método para su utilización..
WO2014145314A3 (en) Methods and compositions for gamma-glutamyl cycle modulation
WO2016069542A3 (en) Lactone compounds and methods of making and using same
GEP201706675B (en) Imidazo-triazine derivatives as pde10 inhibitors
MX2019005723A (es) Inhibidor del receptor del factor de crecimiento de fibroblastos 4 (fgfr4) y metodo de preparacion y uso del mismo.
IN2013MU03422A (ja)
IN2013MU03308A (ja)
IN2013MU03309A (ja)
IN2013MU03421A (ja)
IN2014DN07897A (ja)